Alkem Pipzo 1.125 Injection for Dogs and Cats, 1 piece

Destroys Bacterial Resistance Before It Can Protect the Pathogen: The defining clinical advantage of Pipzo 1.125g lies in its dual-action formulation, where Tazobactam neutralises the very enzyme bacteria use to escape antibiotic therapy. By eliminating beta-lactamase activity at the molecular level, this combination restores Piperacillin's full bactericidal potency against resistant strains that would otherwise evade single-agent penicillin treatment, making it a preferred choice of infectious disease specialists managing complex, treatment-resistant infections.

Eliminates a Broad Spectrum of Life-Threatening Pathogens: Pipzo 1.125g targets an extensive range of clinically significant gram-positive and gram-negative organisms, including the notoriously difficult Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, and Bacteroides fragilis. This broad bactericidal coverage makes it an invaluable first-line option in empirical therapy for serious nosocomial and community-acquired infections before culture and sensitivity results are available, reducing time to effective treatment and improving patient outcomes.

Reinforces Clinical Outcomes in Critical and Hospitalised Patients: In intensive care, post-surgical, and immunocompromised settings, uncontrolled bacterial infections carry the highest risk of progression to life-threatening sepsis. Pipzo 1.125g targets polymicrobial infections at multiple anatomical sites simultaneously, alleviates the bacterial burden rapidly, and supports faster clinical recovery, reducing the risk of systemic complications and the need for escalation to last-resort antibiotic therapies.

Supports Responsible Antibiotic Use Through Targeted Combination Therapy: By incorporating a beta-lactamase inhibitor rather than simply escalating the antibiotic dose, Pipzo 1.125g aligns with global antimicrobial stewardship principles. This approach maximises bactericidal efficacy while minimising the selection pressure that drives broader antibiotic resistance, ensuring that this powerful combination remains therapeutically relevant for future patient populations.

Pharmaceutical-Grade Sterile Formulation for Safe Intravenous Delivery: Pipzo 1.125g is manufactured as a sterile lyophilised powder for reconstitution, ensuring precise dosing, stability, and patient safety during intravenous administration. The formulation meets rigorous Indian Pharmacopoeia (IP) and international cGMP standards, reflecting Alkem Laboratories' unwavering commitment to injectable product quality at every stage of manufacture.

How to Use:

Pipzo Piperacillin and Tazobactam Injection 1.125g must be administered exclusively by a qualified physician, nurse, or trained healthcare professional in a hospital, clinic, or critical care setting. This product is not suitable for self-administration under any circumstances. The injection is prepared by reconstituting the sterile powder with an appropriate volume of a compatible diluent such as sterile water for injection or normal saline, as directed by the prescribing physician or institutional protocol. Once reconstituted, the solution is typically administered by slow intravenous infusion over the recommended infusion period. The dose, frequency, and duration of therapy are determined entirely by the treating physician based on the nature, site, and severity of the infection, the patient's renal function, body weight, clinical status, and microbiological culture results. Do not mix Pipzo with other antibiotics or medications in the same infusion line without confirming compatibility. Always complete the full prescribed course of therapy even if clinical improvement is observed earlier, to prevent the development of antibiotic resistance and ensure complete eradication of the infecting organism.

Storage Advice:

Store unopened Pipzo Piperacillin and Tazobactam Injection 1.125g vials in a cool, dry place below 25 degrees Celsius, protected from direct sunlight, moisture, and excessive heat. Do not freeze the unreconstituted product. Once reconstituted, the solution should be used immediately or stored in accordance with the stability guidelines provided in the product insert, typically within 12 hours at room temperature or 48 hours under refrigeration between 2 and 8 degrees Celsius. Discard any unused reconstituted solution after the recommended storage period. This product must be handled and stored in accordance with institutional infection control protocols and pharmaceutical handling standards. Do not use after the expiry date printed on the vial label and outer carton. Keep out of reach of children and unauthorised personnel.

About the Brand:

Alkem Laboratories Ltd. was founded in 1973 by the late Mr. Samprada Singh in Mumbai, India, and has grown over five decades into one of India's top ten pharmaceutical companies, with a presence spanning over 40 countries across the United States, Europe, Australia, Latin America, Africa, the CIS region, and Southeast Asia. The company's manufacturing facilities are approved by leading international regulatory authorities including the US FDA, UK MHRA, and TGA Australia, and operate in full compliance with WHO-GMP and cGMP standards, reflecting a zero-compromise approach to sterility, potency, and pharmaceutical quality. Alkem's research and development philosophy, anchored by over 500 scientists across six global R&D centres, is driven by the principle of "Extended Lifecare Beyond Boundaries," with sustained investment in complex generics, novel formulations, and biosimilars across therapeutic areas including anti-infectives, cardiology, gastroenterology, and CNS. The company's commitment to ethical manufacturing, sustainable healthcare access, and consistent therapeutic innovation aligns with Animeal's commitment to quality, safety, and science-backed solutions for every patient, human or animal. Discover Alkem Laboratories today.

Disclaimer:

Please note that while Pipzo Piperacillin and Tazobactam Injection 1.125g is formulated from Piperacillin Sodium 1000mg and Tazobactam Sodium 125mg and is indicated for the treatment of moderate to severe bacterial infections in adults and paediatric patients under medical supervision, it is a prescription-only injectable antibiotic and must not be purchased, stored, prepared, or administered without a valid prescription from a licensed medical professional. This product is intended exclusively for use in hospital, clinical, or supervised outpatient settings and is not suitable for home administration or self-use under any circumstances. For patients with known hypersensitivity to penicillins, cephalosporins, or other beta-lactam antibiotics, or those with significant renal impairment, the prescribing physician must conduct a thorough clinical assessment and adjust dosing accordingly before initiating therapy. Animeal supports your health and the health of your patients but does not replace the advice of a qualified veterinary or medical professional.